Recombinant Interferon Alfa-2B medical research studies in Lima, Ohio

Clinical trials serve as crucial medical research that aims at developing or establishing better treatment or diagnostic techniques for the betterment of human lives. Clinical trials using Recombinant Interferon Alfa-2B target various conditions and a few are listed below: Melanoma (Skin), Protocol Specific Unspecified Adult Solid Tumor, Cancer and Neuroendocrine Carcinoma. 1 clinical studies are underway to develop Recombinant Interferon Alfa-2B in Lima, OH.

Some of these active clinical studies are listed below:

• Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor

After enrolling in a research study you may receive medical evaluation and treatment at no cost. We encourage you to enroll in a Recombinant Interferon Alfa-2b clinical trial and help create new cures!